Consumer Research
Grown Rogue Launches Cultivation Ops in Minnesota
MEDFORD – Grown Rogue International Inc. officially began cultivation operations ...
ATB Cormark Conference: Cannabis Operators Focus on Debt and Cash Flow
NEW YORK – Senior executives from major MSOs, including Green ...
Cresco Labs Closes Pennsylvania Dispensary Deal
CHICAGO – Cresco Labs Inc. announced the closing of its ...
Canada Is Now the World’s Largest Cannabis Market
OTTAWA – Supported by 3,420 licensed stores and roughly 7.1 million past-year consumers, Canada's legal industry generated C$5.42 billion (approx. US$3.98 billion) in retail sales in 2025, making it the world's largest federally-legal Cannabis market ...
DEA MJ Rescheduling Transcript Goes Public
WASHINGTON – The Drug Enforcement Administration (DEA) released the complete, corrected transcript from its 11-day marijuana rescheduling hearing, giving the public its first detailed account of the testimony that will guide DEA Chief Administrative Law ...
JARS Cannabis Acquires Sonoran Roots, Claiming Arizona’s Retail Top Spot
PHOENIX – JARS Cannabis and Sonoran Roots have signed a definitive agreement under which JARS will acquire Sonoran Roots, creating Arizona's largest Cannabis retail network – 27 dispensary locations operating under a single platform. The ...
CRB Monitor and NCS Analytics Partner to Bridge the Cannabis Compliance Data Gap
DENVER – Two of the industry's most data-intensive platforms that have long operated on parallel tracks in the Cannabis compliance space announced a formal partnership, combining regulatory licensing records with real-time operational analytics into a ...
Decibel Reports Q2 2026 Financial Results
CALGARY – Decibel Cannabis Co. Inc. reported second-quarter net revenue of $35.6 million for the period ended June 30, 2026, the best three-month result in the company's history. A licensed Canadian Cannabis producer simultaneously raised ...
Organigram Pulls Sanity Group Into a Single Global Structure
TORONTO – Organigram Global Inc. did not wait out the calendar. Roughly four months after the April 2026 closing of its acquisition of Sanity Group GmbH, the Canadian Cannabis producer announced an accelerated integration of ...
Aurora Takes Ownership of UK Patient Supply Chain with Birmingham Acquisitions
EDMONTON – Aurora Cannabis Inc. has acquired two licensed UK pharmaceutical entities, consolidating vertical control of its distribution network in one of Europe's most active medical Cannabis markets. Through a wholly owned subsidiary, Aurora announced ...
Grown Rogue Pushes East with Planned PharmaCann Acquisition
MEDFORD – Grown Rogue International Inc. announced it has taken the first steps toward the planned acquisition of PharmaCann Inc.'s New York license and assets, through the formation of Grown Rogue New York, LLC (GRNY) ...
Portugal Medical Cannabis Outpaces 2025 Export Run Rate
LISBON – Portugal's medicines regulator, Infarmed, has confirmed that the country exported 66,305 kilograms of medical Cannabis between January and June 2026, equivalent to more than 80% of everything it shipped in all of 2025. ...
UMiami Hands Over Its 1994 Ibogaine Research to Washington
LOS ANGELES – The University of Miami has donated its original 1994 investigational new drug (IND) application for ibogaine to the federal government, giving Washington direct operational authority over the foundational FDA authorization that made ...
Research and Markets Report Sets a $28B Target on Cannabis Tech
DUBLIN – The Cannabis industry has transformed from plant cultivation to infrastructure development. Today, institutional-grade technologies reshape the way the global supply chain works, and the numbers behind this evolution are capturing the attention of ...
Europe Medical Cannabis to Reach $13 Billion by 2034, IMARC Group Reports
NEW YORK – A fresh industry report highlights substantial potential in Europe's regulated medical Cannabis market as more countries refine access rules and patient numbers climb. The analysis from IMARC Group points to steady expansion ...
Bioxyne Double-Strikes in LATAM and Europe
SYDNEY – Bioxyne Limited, an international health and life sciences company focused on the manufacturing and distribution of novel medicines, including medical Cannabis, psilocybin, and MDMA, has signed two new commercial agreements – one stretching ...
Rubicon Organics Reports Q1 2026 Financial Results
VANCOUVER – Rubicon Organics Inc. delivered its first-quarter report, revealing results that show both progress and short-term pressures common in an industry shifting toward larger-scale operations – all while balancing strong market share gains with ...
BREAKING: Colorado Passes Landmark Ibogaine Research Bill, Expanding the State’s Natural Medicine Framework
DENVER- Colorado has taken another major step in the evolution of regulated psychedelic medicine. The Colorado legislature has passed House Bill 26-1325, a landmark measure that establishes an ibogaine research pilot program within the state’s ...
The DEA Window: The Real Fight Is Over Who Qualifies as Medical Cannabis
WASHINGTON, D.C. - The real significance of the DEA window is not that the Cannabis industry needs another explanation of legalization. Operators, investors, attorneys, and regulators already understand the limits of federal reform. The more ...
Study: Older Americans Are Turning to Cannabis as an Alternative to Pharmaceuticals
NEW YORK - Older Americans are increasingly looking at Cannabis not as a lifestyle product, but as a practical alternative to traditional pharmaceuticals. A new study highlighted by NORML points to a growing trend among ...
Definium Doses First Patient in Second Phase 3 LSD-Based Trial
NEW YORK – Definium Therapeutics Inc. has taken another step forward in its late-stage testing of a psychedelic-derived treatment for major depressive disorder. The company announced that the first participant received a dose in the ...
Glass House Brands Reports Q1 2026 Financial Results
LONG BEACH – Glass House Brands Inc. released its first-quarter earnings for 2026, showing revenue slightly ahead of internal expectations but down from the year-ago period, with profitability pressured by higher costs and soft wholesale ...
Planet 13 Reports Q1 2026 Financial Results
LAS VEGAS – Planet 13 Holdings Inc. released its first-quarter 2026 financials, reflecting the effects of substantial operational changes and declines in top-line figures, yet showcasing margin gains and cost controls as indications of progress ...
MariMed Reports Q1 2026 Financial Results
NORWOOD – MariMed Inc. turned in another quarter of measured progress in a tough Cannabis market. The company, with operations spanning cultivation, production, and retail facilities across multiple states, has reported year-over-year revenue growth and ...
Grown Rogue Reports Q1 2026 Financial Results
MEDFORD – Grown Rogue International Inc. delivered solid top-line gains in the opening months of 2026, underscoring its push into select markets while managing pressures in more established ones. The company, known for its focus ...
Jushi Reports Q1 2026 Financial Results
BOCA RATON – Jushi Holdings Inc. delivered a quarter of steady operational progress while facing ongoing industry pressures. The multi-state operator recorded year-on-year improvements in revenue and profitability metrics, and completed a significant refinancing of ...
iAnthus Reports Q1 2026 Financial Results
NEW YORK-TORONTO – iAnthus Capital Holdings posted its fiscal first-quarter results for 2026, revealing a company focused on operational tweaks while navigating softer sales in a competitive Cannabis market. The multi-state operator, active across retail ...
Organigram Reports Q2 Fiscal 2026 Results
TORONTO – Organigram Global Inc. released its financial results, marking a quarter shaped by shifts in consumer preferences and execution issues in key categories. The Canadian producer, known for holding the top market share position ...
Cannabis 3.0: From Getting High to Getting Clinical
NEW YORK-Cannabis is entering a new phase, and this one is about much more than consumption. For decades, Cannabis was trapped in prohibition and treated mainly as a legal problem. Then came commercialization, when Cannabis ...
Vireo Growth Reports Q1 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. released its first-quarter 2026 financial results, highlighting the early effects of an active acquisition strategy that has broadened its operations across several key Cannabis markets. The company, which operates a ...
Village Farms Reports Q1 2026 Financial Results
VANCOUVER – Village Farms International Inc., known for its large-scale greenhouse operations, reported gains in revenue and profitability driven largely by exports. Consolidated net sales climbed 27% year-over-year to $50.2 million, with net income attributable ...
Israeli Cannabis Breakthrough Opens New Hope for Fatty Liver Disease
NEW YORK- A new study out of Israel has put Cannabis back into one of the most important conversations in modern medicine: metabolic disease. Researchers at the Hebrew University of Jerusalem have reported that two ...
Why the Endocannabinoid System Is the Future of Cannabis Medicine
NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The ...
Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine
NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune ...
Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine
NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of ...
Cresco Labs Reports Q1 2026 Financial Results
CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With ...
Cronos Group Reports Q1 2026 Financial Results
TORONTO – Cronos Group Inc. posted record net revenue and gross profit for the first quarter of 2026, driven by higher sales volumes, a favorable product mix, and gains in key markets. The Cannabis company ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past two weeks brought measurable movement across federal policy, corporate financial reporting, international deals, and product categories in the U.S. Cannabis sector. Operators absorbed details on rescheduling implications, watched hemp-derived THC ...
